Free Trial

Treace Medical Concepts (TMCI) Competitors

Treace Medical Concepts logo
$6.17 0.00 (0.00%)
Closing price 06/11/2025 04:00 PM Eastern
Extended Trading
$6.17 0.00 (0.00%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TMCI vs. TNDM, CDRE, LQDA, AORT, SSII, PLSE, FNA, KMTS, BLFS, and ESTA

Should you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Tandem Diabetes Care (TNDM), Cadre (CDRE), Liquidia (LQDA), Artivion (AORT), SS Innovations International (SSII), Pulse Biosciences (PLSE), Paragon 28 (FNA), Kestra Medical Technologies (KMTS), BioLife Solutions (BLFS), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

Treace Medical Concepts vs. Its Competitors

Treace Medical Concepts (NASDAQ:TMCI) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, community ranking, earnings, dividends, media sentiment, risk and analyst recommendations.

Treace Medical Concepts presently has a consensus price target of $10.16, suggesting a potential upside of 64.62%. Tandem Diabetes Care has a consensus price target of $34.15, suggesting a potential upside of 58.49%. Given Treace Medical Concepts' higher possible upside, equities research analysts clearly believe Treace Medical Concepts is more favorable than Tandem Diabetes Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treace Medical Concepts
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
Tandem Diabetes Care
0 Sell rating(s)
8 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Treace Medical Concepts had 26 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 32 mentions for Treace Medical Concepts and 6 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.05 beat Treace Medical Concepts' score of 0.12 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Treace Medical Concepts
4 Very Positive mention(s)
3 Positive mention(s)
22 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tandem Diabetes Care
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tandem Diabetes Care has a net margin of -14.84% compared to Treace Medical Concepts' net margin of -30.33%. Tandem Diabetes Care's return on equity of -44.19% beat Treace Medical Concepts' return on equity.

Company Net Margins Return on Equity Return on Assets
Treace Medical Concepts-30.33% -51.12% -26.36%
Tandem Diabetes Care -14.84%-44.19%-11.99%

Treace Medical Concepts has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500.

Tandem Diabetes Care received 564 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 60.76% of users gave Tandem Diabetes Care an outperform vote while only 44.07% of users gave Treace Medical Concepts an outperform vote.

CompanyUnderperformOutperform
Treace Medical ConceptsOutperform Votes
26
44.07%
Underperform Votes
33
55.93%
Tandem Diabetes CareOutperform Votes
590
60.76%
Underperform Votes
381
39.24%

Treace Medical Concepts has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treace Medical Concepts$210.82M1.84-$49.53M-$0.85-7.26
Tandem Diabetes Care$982.95M1.46-$222.61M-$2.78-7.75

84.1% of Treace Medical Concepts shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by insiders. Comparatively, 1.9% of Tandem Diabetes Care shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Tandem Diabetes Care beats Treace Medical Concepts on 10 of the 18 factors compared between the two stocks.

Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMCI vs. The Competition

MetricTreace Medical ConceptsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$388.03M$4.41B$5.57B$8.62B
Dividend YieldN/A42.67%5.28%4.18%
P/E Ratio-6.2328.4427.1120.06
Price / Sales1.8471.85409.88157.10
Price / CashN/A51.0838.2534.64
Price / Book2.755.917.064.70
Net Income-$49.53M$67.63M$3.23B$247.88M
7 Day Performance6.93%2.35%2.88%2.66%
1 Month Performance-14.31%17.24%9.04%6.40%
1 Year Performance1.65%19.59%31.40%14.07%

Treace Medical Concepts Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMCI
Treace Medical Concepts
2.2893 of 5 stars
$6.17
flat
$10.16
+64.6%
+5.5%$388.03M$210.82M-6.23250Trending News
TNDM
Tandem Diabetes Care
4.1392 of 5 stars
$20.22
+2.0%
$35.86
+77.3%
-55.5%$1.35B$982.95M-10.482,600Positive News
CDRE
Cadre
2.9938 of 5 stars
$32.97
+0.6%
$37.00
+12.2%
+7.1%$1.34B$559.81M39.722,240
LQDA
Liquidia
3.7317 of 5 stars
$16.87
+13.1%
$26.67
+58.1%
+2.3%$1.28B$14.14M-10.3550Trending News
Analyst Forecast
Options Volume
High Trading Volume
AORT
Artivion
2.5629 of 5 stars
$28.74
-2.8%
$31.40
+9.3%
+23.6%$1.23B$390.08M-1,437.001,300Short Interest ↓
SSII
SS Innovations International
N/A$5.99
-5.4%
N/AN/A$1.16B$22.13M0.004Positive News
Gap Up
High Trading Volume
PLSE
Pulse Biosciences
1.315 of 5 stars
$16.88
-2.5%
N/A+19.2%$1.14B$700K0.00140
FNA
Paragon 28
N/A$13.11
+0.1%
$12.75
-2.7%
+98.0%$1.10B$256.18M-17.71343,000High Trading Volume
KMTS
Kestra Medical Technologies
N/A$20.68
-8.2%
$27.50
+33.0%
N/A$1.06B$52.64M0.00300
BLFS
BioLife Solutions
2.2902 of 5 stars
$20.69
-5.4%
$31.17
+50.6%
+10.9%$982.78M$87.76M-19.52440Positive News
High Trading Volume
ESTA
Establishment Labs
2.7553 of 5 stars
$33.97
-1.3%
$55.33
+62.9%
-17.3%$982.31M$170.24M-13.17960Positive News

Related Companies and Tools


This page (NASDAQ:TMCI) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners